FUT2 and cystic fibrosis: Patients with non-CF bronchiectasis with homozygous secretors of FUT2 had a poorer prognosis compared with those of nonsecretors and heterozygous secretors and exhibited lower lung function, more exacerbation, and a higher frequency of Pseudomonas aeruginosa-dominated infection (72).